Inhaled tigecycline is effective against <i>Mycobacterium abscessus in vitro</i> and <i>in vivo</i>

Abstract

Inhaled tigecycline may represent a viable treatment option for M. abscessus pulmonary disease, where treatment outcomes are currently very poor. A stable and safe formulation is required to proceed to further pharmacodynamic studies and ultimately clinical trials.